drugset / Trial / NCT00488514

Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

NCT00488514

Phase 3 Completed 656 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study was designed to determine long-term safety of TREXIMET (sumatriptan/naproxen sodium) in adolescents for the acute treatment of migraine.

Timeline

Start
2007-07-13
Primary completion
2009-08-01
Completion
2009-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule
Subject Sumatriptan Unknown

Indications